Expert Video - What is treatment-related AML (or tAML)?
In this video, Dr. Sandra Kurtin explains treatment-related acute myeloid leukemia, or tAML. This type of AML develops in people who previously had cancer treatment with radiation or certain types of chemotherapy. These treatments can damage the cells. You may develop treatment-related AML just two or three years after cancer treatment. Or it may appear as late as 10 years after treatment. The timing depends partly on what type of treatment you had.
Share with family and friends:
Click here to take our SURVEY Your feedback is important to us! We will use your feedback to develop future areas of content about AML which will help other patients, caregivers and families.
This educational activity has been developed by the Myelodysplastic Syndromes Foundation, Inc. and Mechanisms in Medicine Inc.
This activity is supported by educational grants from AbbVie, Celgene Corporation, Daiichi Sankyo, Jazz Pharmaceuticals and Takeda Oncology.
This website is part of the Animated Patient™ series developed by Mechanisms in Medicine Inc., to provide highly visual formats of learning for patients to improve their understanding, make informed decisions, and partner with their healthcare professionals for optimal outcomes.